781 related articles for article (PubMed ID: 27555298)
1. Loss of CTRP1 disrupts glucose and lipid homeostasis.
Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
[TBL] [Abstract][Full Text] [Related]
2. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
3. CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice.
Ren M; Pan J; Yu X; Chang K; Yuan X; Zhang C
J Transl Med; 2022 Oct; 20(1):449. PubMed ID: 36195912
[TBL] [Abstract][Full Text] [Related]
4. CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice.
Tan SY; Lei X; Little HC; Rodriguez S; Sarver DC; Cao X; Wong GW
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E146-E162. PubMed ID: 32421370
[TBL] [Abstract][Full Text] [Related]
5. Partial deficiency of CTRP12 alters hepatic lipid metabolism.
Tan SY; Little HC; Lei X; Li S; Rodriguez S; Wong GW
Physiol Genomics; 2016 Dec; 48(12):936-949. PubMed ID: 27815536
[TBL] [Abstract][Full Text] [Related]
6. Aging and chronic high-fat feeding negatively affect kidney size, function, and gene expression in CTRP1-deficient mice.
Rodriguez S; Little HC; Daneshpajouhnejad P; Fenaroli P; Tan SY; Sarver DC; Delannoy M; Talbot CC; Jandu S; Berkowitz DE; Pluznick JL; Rosenberg AZ; Wong GW
Am J Physiol Regul Integr Comp Physiol; 2021 Jan; 320(1):R19-R35. PubMed ID: 33085906
[TBL] [Abstract][Full Text] [Related]
7. Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice.
Costa DK; Huckestein BR; Edmunds LR; Petersen MC; Nasiri A; Butrico GM; Abulizi A; Harmon DB; Lu C; Mantell BS; Hartman DJ; Camporez JP; O'Doherty RM; Cline GW; Shulman GI; Jurczak MJ
Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E105-16. PubMed ID: 27166280
[TBL] [Abstract][Full Text] [Related]
8. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation.
Kuo YH; Lin CH; Shih CC
J Agric Food Chem; 2015 Mar; 63(9):2479-89. PubMed ID: 25693659
[TBL] [Abstract][Full Text] [Related]
9. C1q/TNF-related protein 2 (CTRP2) deletion promotes adipose tissue lipolysis and hepatic triglyceride secretion.
Lei X; Wong GW
J Biol Chem; 2019 Oct; 294(43):15638-15649. PubMed ID: 31439668
[TBL] [Abstract][Full Text] [Related]
10. CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism.
Peterson JM; Seldin MM; Wei Z; Aja S; Wong GW
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(3):G214-24. PubMed ID: 23744740
[TBL] [Abstract][Full Text] [Related]
11. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
13. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
[TBL] [Abstract][Full Text] [Related]
14. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
15. CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition.
Peterson JM; Aja S; Wei Z; Wong GW
J Biol Chem; 2012 Jan; 287(2):1576-87. PubMed ID: 22086915
[TBL] [Abstract][Full Text] [Related]
16. CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation.
Han S; Park JS; Lee S; Jeong AL; Oh KS; Ka HI; Choi HJ; Son WC; Lee WY; Oh SJ; Lim JS; Lee MS; Yang Y
J Nutr Biochem; 2016 Jan; 27():43-52. PubMed ID: 26456564
[TBL] [Abstract][Full Text] [Related]
17. CTRP13 ablation improves systemic glucose and lipid metabolism.
Chen F; Sarver DC; Saqib M; Zhou M; Aja S; Seldin MM; Wong GW
Mol Metab; 2023 Dec; 78():101824. PubMed ID: 37844630
[TBL] [Abstract][Full Text] [Related]
18. Alterations of hepatic gluconeogenesis and amino acid metabolism in CTRP3-deficient mice.
Maeda T
Mol Biol Rep; 2022 Feb; 49(2):1617-1622. PubMed ID: 34811637
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity.
Smith KR; Hussain T; Karimian Azari E; Steiner JL; Ayala JE; Pratley RE; Kyriazis GA
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E688-E698. PubMed ID: 26884387
[TBL] [Abstract][Full Text] [Related]
20. Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet.
Cairns R; Fischer AW; Blanco-Munoz P; Alvarez-Guaita A; Meneses-Salas E; Egert A; Buechler C; Hoy AJ; Heeren J; Enrich C; Rentero C; Grewal T
PLoS One; 2018; 13(8):e0201310. PubMed ID: 30110341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
